NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 137 filers reported holding NEKTAR THERAPEUTICS in Q3 2023. The put-call ratio across all filers is 5.78 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $32,000 | -98.3% | 1,612 | -98.5% | 0.01% | -98.4% |
| Q4 2020 | $1,832,000 | +13.3% | 107,736 | +16.0% | 0.32% | +3.9% |
| Q3 2020 | $1,617,000 | +3.0% | 92,836 | +29.2% | 0.31% | -10.8% |
| Q2 2020 | $1,570,000 | +53.2% | 71,836 | +45.6% | 0.34% | +28.5% |
| Q1 2020 | $1,025,000 | +75.5% | 49,336 | +86.9% | 0.27% | +62.8% |
| Q4 2019 | $584,000 | +16.6% | 26,400 | -11.6% | 0.16% | -6.3% |
| Q3 2019 | $501,000 | +21.0% | 29,874 | +125.1% | 0.18% | +0.6% |
| Q2 2019 | $414,000 | +24.0% | 13,274 | +28.0% | 0.17% | +22.5% |
| Q1 2019 | $334,000 | +16.8% | 10,374 | +46.2% | 0.14% | -4.1% |
| Q4 2018 | $286,000 | +13.9% | 7,098 | +7.6% | 0.15% | +5.7% |
| Q3 2018 | $251,000 | – | 6,598 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,000,000 | $67,200,000 | 3.35% |
| First Light Asset Management, LLC | 763,403 | $25,650,000 | 3.33% |
| BRIDGER MANAGEMENT, LLC | 1,238,489 | $41,613,000 | 3.29% |
| Rhenman & Partners Asset Management AB | 734,445 | $24,677,000 | 2.89% |
| BB BIOTECH AG | 2,020,676 | $67,895,000 | 1.71% |
| Gs Investments, Inc. | 54,200 | $1,821,120,000 | 1.43% |
| Artal Group S.A. | 900,000 | $30,240,000 | 1.24% |
| Cormorant Asset Management, LP | 500,000 | $16,800,000 | 1.14% |
| TOBAM | 640,547 | $21,522,000 | 1.09% |
| Bellevue Group AG | 430,026 | $14,449,000 | 0.80% |